Source: University of Missouri College of Veterinary Medicine
When Mary Winter’s rescue dog, Sadie, was diagnosed with lymphoma, she turned to the University of Missouri College of Veterinary Medicine for cutting-edge treatment. Under the care of Dr. Jeffrey Bryan, Sadie qualified for a clinical trial using chimeric antigen receptor (CAR) T-cell therapy, an innovative treatment funded by the National Cancer Institute.
This therapy involves injecting human CAR T-cells directly into a dog’s lymph nodes rather than through the bloodstream, allowing them to target and destroy cancer cells more effectively. Using advanced PET scan technology, researchers at Mizzou tracked the T-cells’ movements, confirming their attack on Sadie’s cancer. Sadie responded well, with reduced lymph node swelling and a return to normalcy. The study aims to expand trials to more dogs, with hopes of translating findings to human cancer treatment, reinforcing Mizzou’s commitment to advancing comparative oncology for both pets and people.
Read the full story HERE: https://cvm.missouri.edu/new-therapy-for-dogs-with-cancer-shows-promise/